Thirty non-randomised studies were included in the review (n=23,683): 25 studies of radical/modified mastectomy (n=23,051); three studies of inflammatory breast cancer (n=243); and three studies of skin-sparing mastectomy (n=389). Some studies had overlapping populations or involved different patient groups. The number of patients included in studies ranged from 23 to 4,181. Median length of follow-up ranged from 21 to 216 months. The years studied varied from 1970 to 2006, where stated.
All clinical groups: There was a significantly greater risk of relapse in women with close margin compared to women without close margin (RR 2.57, 95% CI 1.94 to 3.41, I2=19%; 11 studies, n=3,646).
Non-inflammatory breast cancer treated with radical/modified mastectomy: With no radiotherapy, there was a significantly greater risk of relapse in women with close margin compared to women without close margin (RR 2.60, 95% CI 1.79 to 3.77, I2=19%; five studies, n=2,825). With some use of radiotherapy (one study, n=100) or all patients receiving radiotherapy (one study, n=268), there was no statistically significant difference in risk of relapse in women with close margin compared to women without close margin. With no radiotherapy there was a significantly greater risk of relapse in women with muscle or fascia invasion compared to women without invasion (RR 1.72, 95% CI 1.03 to 2.86, I2=76%; four studies, n=5,071).
Inflammatory breast cancer: There was a significantly greater risk of relapse in women with close margin compared to women without close margin (RR 3.08, 95% CI 1.77 to 5.36, I2=36%; three studies, n=243).
Skin-sparing mastectomy: There was no statistically significant difference in relapse rate in women with close margin compared to women without close margin (one study, n=210).